Table 2 Characteristics of pancreatic cancer cases in pancreatitis and control groups.

From: Incidence and risk of pancreatic cancer in patients with acute or chronic pancreatitis: a population-based cohort study

 

Pancreatic cancer

Controls

 

Pancreatitis

 

SD

N, %

5901

100

12,780

100

 

Sex

 Male

3629

61.5

7641

59.8

0.03

 Female

2272

38.5

5139

40.2

 

Ages

 Mean, SD

69.0

9.3

65.5

10.7

0.35

Hepatic fibrosis/cirrhosis

 No

5602

94.93

12,062

94.38

0.03

 Yes

299

5.07

718

12.17

 

Alcoholic liver disease

 No

5260

89.14

11,045

86.42

0.09

 Yes

641

10.9

1735

13.6

 

Gallstones

 No

5059

85.7

10,039

78.6

0.22

 Yes

842

14.3

2741

21.4

 

ALT (U/L)

 < 40

5310

90.0

11,271

88.2

0.06

 41+

584

9.9

1497

11.7

 

 Missing

7

0.1

12

0.1

 

GGT (U/L)

 < 76

4911

83.2

10,236

80.2

0.08

 76+

984

16.7

2537

19.8

 

 Missing

6

0.1

7

0.0

 

BMI (Kg/m2)

 < 18.5

143

2.4

313

2.5

0.02

 18.5–24.9

3557

60.3

7711

60.3

 

 25.0–29.9

2004

34.0

4278

33.5

 

 30+

197

3.3

478

3.7

 

FPG (mg/dL)

 < 110

4223

71.6

9186

71.9

0.02

 110–125

842

14.3

1791

14.0

 

 126+

830

14.1

1796

14.0

 

 Missing

6

0.1

7

0.1

 

Cholesterol (mg/dL)

 < 200

3305

56.0

7144

55.9

0.01

 200–239

1833

31.1

3969

31.1

 

 ≥ 240

756

12.8

1656

12.9

 

 Missing

7

0.1

11

0.1

 

Smoking (pack-year)

 None

3856

65.3

7701

60.3

0.12

 < 10

293

5.0

738

5.8

 

 11–20

551

9.3

1308

10.2

 

 21–30

481

8.2

1239

9.7

 

 31–40

227

3.9

671

5.3

 

 40<

380

6.4

909

7.1

 

 Missing

113

1.9

214

1.7

 

Alcohol (drinks/week)

 None

3126

53.0

6582

51.5

0.12

< One/month

1055

17.9

2453

19.2

 

 < One/week

393

6.7

745

5.8

 

 ≥ One/week

655

11.1

1822

14.3

 

 Missing

672

11.3

1178

9.2

 

Physical activity

 None

3172

53.8

6830

53.4

0.04

 Light-moderate

1257

21.3

2887

22.6

 

 Vigorous

1370

23.2

2863

22.4

 

Missing

102

1.7

200

1.6

 
  1. SD standardized mean difference, ALT alanine transaminase, GGT gamma-glutamyl transferase, BMI body mass index, FPG fasting plasma glucose.